Search Results 2191-2200 of 16248 for Epilepsy (Partial Onset)
The purpose of this study is to test the hypothesis that benralizumab will reduce exacerbation rates compared with placebo on top of standard-of-care therapy in ...
Venous thromboembolism is a condition in which a blood clot forms in a vein and then breaks off and moves through the bloodstream. Patients with cancer are at ...
Undergoing stereo EEG for localization of epilepsy will be recruited. English speaking. Exclusion Criteria: Patients under the age of 18. Non-English ...
Subjects on GSK2330672 will also receive placebo tablets to maintain blinding. The total duration of a subject's participation will be up to 45 days of ...
The investigators goal is to evaluate the role of XOLAIR® in treatment of Acute Tubulointerstitial Nephritis (AIN) with the goal of shortening the duration and ...
Can early hemodialysis improve outcomes? Hemodial ... Angiotensin II receptor 1 antibodies associate with post-transplant focal segmental glomerulosclerosis and ...
... duration of the active Treatment Period. If female of child-bearing potential, must be nonpregnant and nonlactating and must agree to use an effective ...
Developing Interventions for Healthy Sleep in Native American Families. Rochester, Minn. The purpose of this study is to gather information on sleep duration ...
A second part of this study will involve using a Fitbit consumer wearable device to obtain sleep and activity data on participants for 2 months in duration. .
About this study. The purpose of this study is to evaluate abdominal pain response to BOS-589 in participants with diarrhea-predominant Irritable Bowel ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The deadline to have twice the impact to advance healthcare research is May 15.